Companies / JNJ vs VRTX
JNJ vs VRTX: Johnson & Johnson and Vertex Pharmaceuticals
Johnson & Johnson (JNJ) reported $94.2B in revenue against a 28.5% net margin, while Vertex Pharmaceuticals (VRTX) reported $12.0B at a 32.9% net margin, most recently.
| Metric | JNJ | VRTX |
|---|---|---|
| Revenue | $94.2B | $12.0B |
| Net Income | $26.8B | $4.0B |
| Gross Margin | 67.9% | 86.2% |
| Operating Margin | — | 34.8% |
| EPS (Diluted) | $11.03 | $15.32 |
| Free Cash Flow | $19.7B | $3.2B |
| Total Debt | $49.9B | — |
| P/E Ratio | 18.8× | 29.6× |
| P/B Ratio | n/m | 6.2× |
| Stock Price | $272.48 | $542.69 |
Free: last 5 years
| Fiscal year | FY2008 🔒 | FY2010 🔒 | FY2011 🔒 | FY2012 🔒 | FY2013 🔒 | FY2014 🔒 | FY2016 🔒 | FY2017 🔒 | FY2018 🔒 | FY2019 🔒 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JNJ Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $82.6B | $78.7B | $85.2B | $88.8B | $94.2B |
| VRTX Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $7.6B | $8.9B | $9.9B | $11.0B | $12.0B |